{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T12:30:35Z","timestamp":1771331435615,"version":"3.50.1"},"reference-count":50,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2024.2719","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T12:38:58Z","timestamp":1705581538000},"source":"Crossref","is-referenced-by-count":4,"title":["Exploring the anticancer potential of hydrogen sulfide and BAY\u2011876 on clear cell renal cell carcinoma cells: Uncovering novel mutations in VHL and KDR genes among ccRCC patients"],"prefix":"10.3892","volume":"20","author":[{"given":"Peshraw","family":"Hamadamin","sequence":"first","affiliation":[{"name":"Department of Biology, College of Science, Salahaddin University\u2011Erbil, Erbil, Kurdistan 44002, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalthum","family":"Maulood","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Education, Salahaddin University\u2011Erbil, Erbil, Kurdistan 44002, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"key20240227092332_b1-MCO-20-3-02719","first-page":"32","article-title":"Renal cell carcinoma: An overview of the epidemiology, diagnosis, and treatment","volume":"39","author":"Bahadoram","year":"2022","journal-title":"G Ital Nefrol"},{"key":"key20240227092332_b2-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"7946","key":"key20240227092332_b3-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097946","article-title":"The tumor immune microenvironment in clear cell renal cell carcinoma","volume":"24","author":"Monjaras-Avila","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"665","key":"key20240227092332_b4-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030665","article-title":"Clear cell renal cell carcinoma: From biology to treatment","volume":"15","author":"Kase","year":"2023","journal-title":"Cancers (Basel)"},{"key":"key20240227092332_b5-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala","year":"2020","journal-title":"World J Oncol"},{"key":"key20240227092332_b6-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","article-title":"Clear cell renal cell carcinoma ontogeny and mechanisms of lethality","volume":"17","author":"Jonasch","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"key20240227092332_b7-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","article-title":"Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors","volume":"14","author":"Nickerson","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20240227092332_b8-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-020-0301-x","article-title":"Genomic profiling in renal cell carcinoma","volume":"16","author":"Dizman","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"key20240227092332_b9-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pathol.2020.10.002","article-title":"Clear cell papillary renal cell carcinoma: An update after 15 years","volume":"53","author":"Williamson","year":"2021","journal-title":"Pathology"},{"issue":"186","key":"key20240227092332_b10-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-01961-3","article-title":"Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma","volume":"40","author":"Sharma","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"issue":"17009","key":"key20240227092332_b11-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"4059","key":"key20240227092332_b12-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14164059","article-title":"Epidemiology and prevention of renal cell carcinoma","volume":"14","author":"Makino","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20240227092332_b13-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15586\/jkcvhl.v8i1.170","article-title":"Hypoxia-inducible factor-2\u03b1 as a novel target in renal cell carcinoma","volume":"8","author":"Choi","year":"2021","journal-title":"J Kidney Cancer VHL"},{"key":"key20240227092332_b14-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa065044","article-title":"Sunitinib versus interferon alfa in metastatic renal-cell carcinoma","volume":"356","author":"Motzer","year":"2007","journal-title":"N Engl J Med"},{"issue":"100929","key":"key20240227092332_b15-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100929","article-title":"Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers","volume":"67","author":"Jin","year":"2023","journal-title":"Drug Resist Updat"},{"key":"key20240227092332_b16-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/jnci\/djk008","article-title":"Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib","volume":"99","author":"Rini","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"33","key":"key20240227092332_b17-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010033","article-title":"Ovarian cancer relies on glucose transporter 1 to fuel glycolysis and growth: Anti-tumor activity of BAY-876","volume":"11","author":"Ma","year":"2018","journal-title":"Cancers (Basel)"},{"key":"key20240227092332_b18-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s11010-022-04443-y","article-title":"Hydrogen sulfide and metal interaction: The pathophysiological implications","volume":"477","author":"Mantle","year":"2022","journal-title":"Mol Cell Biochem"},{"issue":"323","key":"key20240227092332_b19-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020323","article-title":"hydrogen sulfide in pharmacotherapy, beyond the hydrogen sulfide-donors","volume":"10","author":"Zaorska","year":"2020","journal-title":"Biomolecules"},{"issue":"3389","key":"key20240227092332_b20-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113389","article-title":"Hydrogen sulfide biology and its role in cancer","volume":"27","author":"Khattak","year":"2022","journal-title":"Molecules"},{"key":"key20240227092332_b21-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ars.2017.7058","article-title":"A review of hydrogen sulfide synthesis, metabolism, and measurement: Is modulation of hydrogen sulfide a novel therapeutic for cancer?","volume":"31","author":"Cao","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"key20240227092332_b22-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bcp.2017.11.014","article-title":"A review of hydrogen sulfide (H(2)S) donors: Chemistry and potential therapeutic applications","volume":"149","author":"Powell","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"key20240227092332_b23-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.3892\/ol.2014.1962","article-title":"786-0 renal cancer cell line-derived exosomes promote 786-0 cell migration and invasion in vitro","volume":"7","author":"Chen","year":"2014","journal-title":"Oncol Lett"},{"issue":"217","key":"key20240227092332_b24-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01686-7","article-title":"circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-\u03baB-induced CCL5 secretion","volume":"21","author":"Gu","year":"2022","journal-title":"Mol Cancer"},{"key":"key20240227092332_b25-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s00345-018-2447-8","article-title":"WHO\/ISUP classification, grading and pathological staging of renal cell carcinoma: Standards and controversies","volume":"36","author":"Warren","year":"2018","journal-title":"World J Urol"},{"key":"key20240227092332_b26-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2214\/AJR.21.25493","article-title":"Update on the role of imaging in clinical staging and restaging of renal cell carcinoma based on the AJCC 8th edition, from the AJR special series on cancer staging","volume":"217","author":"Elkassem","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"key20240227092332_b27-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pathol.2020.08.007","article-title":"Staging of renal cell carcinoma: Current progress and potential advances","volume":"53","author":"Delahunt","year":"2021","journal-title":"Pathology"},{"issue":"665","key":"key20240227092332_b28-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12926","article-title":"Association between the serum concentrations and mutational status of IL-8, IL-27 and VEGF and the expression levels of the hERG potassium channel gene in patients with colorectal cancer","volume":"22","author":"Abid","year":"2021","journal-title":"Oncol Lett"},{"key":"key20240227092332_b29-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00428-014-1629-z","article-title":"Mutational status of VHL gene and its clinical importance in renal clear cell carcinoma","volume":"465","author":"Alves","year":"2014","journal-title":"Virchows Arch"},{"issue":"2536","key":"key20240227092332_b30-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82244-x","article-title":"In vitro anticancer activity of hydrogen sulfide and nitric oxide alongside nickel nanoparticle and novel mutations in their genes in CRC patients","volume":"11","author":"Housein","year":"2021","journal-title":"Sci Rep"},{"key":"key20240227092332_b31-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: Lessons from gnomAD","volume":"43","author":"Gudmundsson","year":"2022","journal-title":"Hum Mutat"},{"key":"key20240227092332_b32-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC cancer gene census: Describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"key20240227092332_b33-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","article-title":"GeneMANIA update 2018","volume":"46","author":"Franz","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"key20240227092332_b34-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ejphar.2014.11.021","article-title":"Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells","volume":"746","author":"Sato","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"9898","key":"key20240227092332_b35-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179898","article-title":"Sunitinib versus pazopanib dilemma in renal cell carcinoma: New Insights into the in vitro metabolic impact, efficacy, and safety","volume":"23","author":"Amaro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20240227092332_b36-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/ijc.25543","article-title":"Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor","volume":"128","author":"Singer","year":"2011","journal-title":"Int J Cancer"},{"key":"key20240227092332_b37-MCO-20-3-02719","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3889\/oamjms.2022.10904","article-title":"Assessment of the expression of GLUT1 in renal cell carcinoma and its various subtypes","volume":"10","author":"Abdolahi","year":"2022","journal-title":"Open Access Maced J Med Sci"},{"issue":"508","key":"key20240227092332_b38-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03173-x","article-title":"TRIM38 triggers the uniquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer","volume":"19","author":"Wang","year":"2021","journal-title":"J Transl Med"},{"key":"key20240227092332_b39-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.5489\/cuaj.67","article-title":"Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects","volume":"1","author":"Kollmannsberger","year":"2007","journal-title":"Can Urol Assoc J"},{"key":"key20240227092332_b40-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.niox.2015.06.001","article-title":"Inhibition of endogenous hydrogen sulfide production in clear-cell renal cell carcinoma cell lines and xenografts restricts their growth, survival and angiogenic potential","volume":"49","author":"Sonke","year":"2015","journal-title":"Nitric Oxide"},{"key":"key20240227092332_b41-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.21873\/anticanres.11709","article-title":"Increased nicotinamide phosphoribosyltransferase and cystathionine-\u03b2-synthase in renal oncocytomas, renal urothelial carcinoma, and renal clear cell carcinoma","volume":"37","author":"Shackelford","year":"2017","journal-title":"Anticancer Res"},{"issue":"591","key":"key20240227092332_b42-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4508-1","article-title":"Endogenous H(2)S producing enzymes are involved in apoptosis induction in clear cell renal cell carcinoma","volume":"18","author":"Breza","year":"2018","journal-title":"BMC Cancer"},{"key":"key20240227092332_b43-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2019.04.031","article-title":"A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K\/AKT\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways","volume":"455","author":"Dong","year":"2019","journal-title":"Cancer Lett"},{"key":"key20240227092332_b44-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"614","DOI":"10.4103\/njcp.njcp_57_20","article-title":"Clinicopathological comparison of VHL expression as a prognostic tumor marker in renal cell carcinoma: A single center experience","volume":"24","author":"Sekar","year":"2021","journal-title":"Niger J Clin Pract"},{"key":"key20240227092332_b45-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1111\/j.1464-410X.2011.10661.x","article-title":"Genetic pathways involved in carcinogenesis of clear cell renal cell carcinoma: Genomics towards personalized medicine","volume":"109","author":"Audenet","year":"2012","journal-title":"BJU Int"},{"key":"key20240227092332_b46-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"key20240227092332_b47-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/gcc.10054","article-title":"Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: Relationship to clinicopathological parameters","volume":"34","author":"Kondo","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"issue":"169","key":"key20240227092332_b48-MCO-20-3-02719","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12430","article-title":"Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing","volume":"21","author":"Lin","year":"2021","journal-title":"Oncol Lett"},{"key":"key20240227092332_b49-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/1389200221666201019143252","article-title":"Tumor angiogenesis and VEGFR-2: Mechanism, pathways and current biological therapeutic interventions","volume":"22","author":"Shah","year":"2021","journal-title":"Curr Drug Metab"},{"key":"key20240227092332_b50-MCO-20-3-02719","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/15384047.2018.1537575","article-title":"The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer","volume":"20","author":"Zhu","year":"2019","journal-title":"Cancer Biol Ther"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T07:23:40Z","timestamp":1709018620000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2024.2719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,1,18]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2024.2719","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"article-number":"21"}}